Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

5.6%

1 terminated/withdrawn out of 18 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

56%

10 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4

8(57.1%)

N/A

4(28.6%)

Phase 3

2(14.3%)

14Total

Phase 4(8)

N/A(4)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials

NCT07358910Recruiting

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Role: collaborator

NCT05306067Completed

Plasmodium Falciparum Genomic Intelligence in Mozambique

Role: collaborator

NCT06524336Active Not Recruiting

Host Immune Dynamics Following Seasonal Malaria Chemoprevention in African Children

Role: lead

NCT06232954Not ApplicableRecruiting

Evaluation of the Protective Efficacy of a Spatial Repellent to Reduce Malaria Prevalence in Uganda

Role: collaborator

NCT06337253Phase 4Not Yet Recruiting

Seasonal Malaria Chemoprevention Rapid Assessment Study Mozambique

Role: lead

NCT05471544Phase 3Unknown

Effectiveness, Feasibility and Acceptability of Seasonal Malaria Chemoprevention in Aweil South County in South Sudan

Role: lead

NCT06318078Not ApplicableUnknown

Buikwe Electronic Community Health Information System Impact Study

Role: lead

NCT06155448Not ApplicableActive Not Recruiting

Perennial Malaria Chemoprevention (PMC) Effect Study

Role: lead

NCT05946642Phase 3Unknown

Innovative Intermittent Preventive Treatment Approaches to Reduce Malaria Burden in School-age Children in Burkina Faso

Role: lead

NCT05186363Phase 4Unknown

Effectiveness of Seasonal Malaria Chemoprevention in Nampula Province, Mozambique: Type Two Hybrid Implementation Study

Role: lead

NCT05323721Phase 4Unknown

Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Karamoja Region, Uganda

Role: lead

NCT05478954Phase 4Unknown

Chemoprevention Efficacy Study in Burkina Faso

Role: lead

NCT05979896Phase 4Unknown

Chemoprevention Efficacy Study Nigeria

Role: lead

NCT02878031Phase 4Completed

Community Case Management of Chest Indrawing Pneumonia

Role: lead

NCT02926625Phase 4Completed

Universal Versus Conditional Three-day Follow-up Visit for Children With Unclassified Fever

Role: lead

NCT03067558Terminated

Acute Respiratory Infection Diagnostic Aids (ARIDA) Controlled Accuracy Evaluation Protocol

Role: lead

NCT02434952Phase 4Completed

Safety and Tolerability of Low Dose Primaquine

Role: lead

NCT01972321Not ApplicableCompleted

ICCM of Common Childhood Diseases: Mozambique and Uganda

Role: lead

All 18 trials loaded